Table 1.
NIH/NICHD, 19925 | ESHRE/ASRM (Rotterdam criteria), 20046 | Androgen excess society guideline, 20067 |
---|---|---|
• Exclude other androgen excess or related disorders | • Exclude other androgen excess or related disorders | • Exclude other androgen excess or related disorder |
• Include the following (clinical or biochemical hyperandrogenism or both and menstrual dysfunction) | • Include two of the following (clinical or biochemical hyperandrogenism or both; oligo- or anovulation; and polycystic ovaries) | • Include the following (clinical or biochemical hyperandrogenism or both and ovarian dysfunction, polycystic ovaries, or both) |
Abbreviations: NIH/NICHD, National Institutes of Health/National Institute of Child Health and Human Disease; ESHRE/ASRM, European Society for Human Reproduction and Embryology/American Society for Reproductive medicine.